Used as a key intermediate in the synthesis of non-nucleoside reverse transcriptase inhibitors (NNRTIs), particularly in antiviral medications targeting HIV. Its structure enables effective binding to the reverse transcriptase enzyme, making it valuable in pharmaceutical research and development. Also employed in the preparation of bioactive molecules and heterocyclic compounds for drug discovery. Commonly utilized in medicinal chemistry for optimizing lead compounds due to its favorable reactivity and ability to enhance pharmacokinetic properties.